These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1576805)

  • 1. Metabolic effects of monomeric insulin analogues of different receptor affinity.
    Robertson DA; Singh BM; Hale PJ; Jensen I; Nattrass M
    Diabet Med; 1992 Apr; 9(3):240-6. PubMed ID: 1576805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absorption kinetics and action profiles of subcutaneously administered insulin analogues (AspB9GluB27, AspB10, AspB28) in healthy subjects.
    Kang S; Brange J; Burch A; Vølund A; Owens DR
    Diabetes Care; 1991 Nov; 14(11):1057-65. PubMed ID: 1797487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic effects of low-dose incremental insulin infusion in diabetic man.
    Hale PJ; Black E; Nattrass M
    Horm Metab Res; 1986 Feb; 18(2):129-33. PubMed ID: 3516823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired glucose tolerance is characterized by multiple abnormalities in the regulation of intermediary metabolism.
    Krentz AJ; Singh BM; Nattrass M
    Diabet Med; 1991 Nov; 8(9):848-54. PubMed ID: 1837511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ketone bodies on basal and insulin-stimulated glucose utilization in man.
    Beylot M; Khalfallah Y; Riou JP; Cohen R; Normand S; Mornex R
    J Clin Endocrinol Metab; 1986 Jul; 63(1):9-15. PubMed ID: 3519651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of obesity on circulating intermediary metabolite concentrations in the absence of impaired glucose tolerance.
    Robertson DA; Singh BM; Nattrass M
    Int J Obes; 1991 Oct; 15(10):635-45. PubMed ID: 1752724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabolic response to hyperglycaemic clamping in insulin-dependent diabetes.
    Nosadini R; Noy GA; Alberti KG; Hodson A; Orskoy H
    Diabetologia; 1981 Feb; 20(2):113-7. PubMed ID: 7009290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in insulin sensitivity between normal men and women.
    Hale PJ; Wright JV; Nattrass M
    Metabolism; 1985 Dec; 34(12):1133-8. PubMed ID: 3906353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired glucose tolerance in obesity is associated with insensitivity to insulin in multiple aspects of metabolism as assessed by a low dose incremental insulin infusion technique.
    Robertson DA; Singh BM; Nattrass M
    Diabet Med; 1991 Oct; 8(8):718-25. PubMed ID: 1838062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.
    Pampanelli S; Torlone E; Ialli C; Del Sindaco P; Ciofetta M; Lepore M; Bartocci L; Brunetti P; Bolli GB
    Diabetes Care; 1995 Nov; 18(11):1452-9. PubMed ID: 8722069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic profiles in patients with insulinoma.
    Hale PJ; Nattrass M
    Clin Endocrinol (Oxf); 1989 Jan; 30(1):29-38. PubMed ID: 2550166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic abnormalities in obese patients with impaired glucose tolerance.
    Robertson DA; Singh BM; Baddeley RM; Nattrass M
    Diabet Med; 1990 Jan; 7(1):45-9. PubMed ID: 2137062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential metabolic actions of biosynthetic insulin analogues in normal man assessed by stable isotopic tracers.
    Gelding SV; Coldham N; Anyaoku V; Heslop K; Halliday D; Johnston DG
    Diabet Med; 1993 Jun; 10(5):470-6. PubMed ID: 8334829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metabolic and hormonal response to acute normoglycaemia in type 1 (insulin-dependent) diabetes: studies with a glucose controlled insulin infusion system (artificial endocrine pancreas).
    Nosadini R; Noy GA; Nattrass M; Alberti KG; Johnston DG; Home PD; Orskov H
    Diabetologia; 1982 Sep; 23(3):220-8. PubMed ID: 6751902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action profiles of fast onset insulin analogues.
    Heinemann L; Starke AA; Heding L; Jensen I; Berger M
    Diabetologia; 1990 Jun; 33(6):384-6. PubMed ID: 2199281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple aspects of insulin resistance. Comparison of glucose and intermediary metabolite response to incremental insulin infusion in IDDM subjects of short and long duration.
    Singh BM; Palma MA; Nattrass M
    Diabetes; 1987 Jun; 36(6):740-8. PubMed ID: 3552803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of epinephrine and somatostatin-induced insulin deficiency on ketone body kinetics and lipolysis in man.
    Weiss M; Keller U; Stauffacher W
    Diabetes; 1984 Aug; 33(8):738-44. PubMed ID: 6146545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal regulation of intermediary metabolism after oral glucose ingestion in myotonic dystrophy.
    Krentz AJ; Coles NH; Williams AC; Nattrass M
    Metabolism; 1990 Sep; 39(9):938-42. PubMed ID: 2202885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the short-acting insulin analog [Lys(B28),Pro(B29)] on postprandial blood glucose control in IDDM.
    Torlone E; Pampanelli S; Lalli C; Del Sindaco P; Di Vincenzo A; Rambotti AM; Modarelli F; Epifano L; Kassi G; Perriello G; Brunetti P; Bolli G
    Diabetes Care; 1996 Sep; 19(9):945-52. PubMed ID: 8875087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of two doses of glibenclamide upon metabolic rhythms in maturity-onset diabetics.
    Nattrass M; Hinks L; Smythe P; Todd PG; Alberti KG
    Diabete Metab; 1978 Sep; 4(3):175-80. PubMed ID: 101402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.